GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer. - Ye, Ling; Zheng, Nannan; Liu, Fangming; Fu, Huirong; Liu, Yifei; Yang, Ying; Qi, Ruixue; Wu, Duojiao; Shi, Lin; Song, Dongli (Clinical & Translational Discovery, 2026)